Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study
Clinical Therapeutics, 06/23/09
Zhao RK et al. - In these healthy Chinese subjects, AUC and Cmax increased proportionally with the dose, whereas t1/2 was independent of the dose. Linear PK properties were found at doses of 30 to 90 mg. No statistically significant differences were observed between the PK parameters for the subjects in the multiple-dose phase (t1/2, CL, Vd) and those for subjects in the single-dose phase. The AUC and Cmax were greater after administration of multiple doses than after administration of a single dose, suggesting du-loxetine accumulation with multiple-dose administration of 30 mg.
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pediatric antifungal agents
Current Opinion in Infectious Diseases, 10/28/09
Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study
Clinical Drug Investigation, 10/15/09
Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options
Current Drug Targets, 10/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


